rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Astrazeneca Oxford

Subscribe via RSS
Rediff.com  »  News  »   Astrazeneca Oxford

  News for Astrazeneca Oxford

  • News
  • Business

AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

 In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

AstraZeneca admits in court: Covishield causes TTS

 United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......

AstraZeneca withdraws COVID-19 vaccine globally: Report

 United Kingdom-based pharmaceutical major AstraZeneca has started global withdrawal of its COVID-19 vaccine, which was provided in India as 'Covishield' in partnership with Serum Institute of......

AstraZeneca's COVID-19 Vaccine: The TTS Factor

 'It is admitted that the AZ vaccine can, in very rare cases, cause TTS.' IMAGE: A vial labelled 'AstraZeneca COVID-19 Vaccine'. Photograph: Illustration/Dado Ruvic/Reuters   The controversial......

Oxford-AstraZeneca Covid jab faces legal threat in UK over side effects: Report

 The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal challenge in the high court in London, a UK media report said on......

Sensex, Nifty extend record run on vaccine booster

 Among major Sensex movers, Ultratech Cement rose over 4 per cent, Bajaj Finance by 2.63 per cent and Maruti by 2 per cent. BSE Sensex closed up by 133.14 points at a record high of 47,746.22. NSE......

Reports of coal crisis baseless: Sitharaman

 Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as “absolutely baseless”, saying India......

Serum Institute to start phase-2 trials of Oxford-AstraZeneca vaccine

 The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......

Meet Adar Poonawala, India's COVID-19 vaccine man

 Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

India to play a big role in containing Covid pandemic: Bill Gates

 India's willingness to play a big role in the manufacturing and to allow some of those vaccines to go to other developing countries will be an absolutely critical part of containing the pandemic,......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2025 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances